Singapore studies unveil insights to impact of COVID-19 and vaccination on mother and child health.
14 November 2023, Singapore – Two COVID-19 studies on the Singapore population by KK Women’s and Children’s Hospital (KKH) have unveiled insights on COVID-19’s impact on mother and child health.
These studies provide valuable additions to the limited studies on COVID-19 in Singapore and Asia.
Study on Pregnant Women:
Vaccination during pregnancy is recommended to reduce the risk of COVID-19 infection among newborns
The study [1] by KKH, Singapore General Hospital, National Centre for Infectious Diseases and the Ministry of Health found that COVID-19 vaccination (mRNA-based COVID-19 vaccine) taken during pregnancy was associated with a reduced risk of COVID-19 infections among infants up to six months of age.
Maternal COVID-19 vaccination was found to be up to 44.4 per cent [2] effective in protecting infants against SARS-CoV-2 infection up to six months after birth. Protection was not found in infants whose mothers were vaccinated prior to their pregnancies [3] . This is particularly important because to date, there is no available vaccine for vulnerable infants up to six months old.
Associate Professor Yung Chee Fu, Senior Author of the study, and Senior Consultant, Infectious Disease Service, Department of Paediatrics, KKH said, “Maternal COVID-19 vaccination remains the most effective way to protect mothers, their pregnancies as well as their newborns after delivery against severe outcomes from SARS-CoV-2 infection. This study reinforces the importance of receiving boosters and keeping up to date with the recommended vaccination doses during pregnancy. Pregnant mothers cannot rely on the COVID-19 vaccines they received before pregnancy for protection of their newborns.”
This study was conducted between 1 January 2022 and 31 March 2023, a period dominated by the Omicron variants. It involved 7,292 infants who were categorised into three main groups: infants born to mothers who were unvaccinated, infants born to mothers who were vaccinated before pregnancy and infants born to mothers who were vaccinated during pregnancy. Some additional findings include:
Assoc Prof Yung added, “Our study plugs the gap on real-world effectiveness data on maternal COVID-19 vaccination against the Omicron XBB variant. More importantly, it will help pregnant women make informed vaccination decisions regarding protecting their babies against COVID-19 infections.”
Study on Children and Youths under 18 years:
Vaccination could potentially be protective against Long COVID in children and youths
The KKH study [4] found that 16.8 per cent or one in six children and youths under the age of 18 developed Long COVID after an acute COVID-19 infection. For this group, one or more symptoms persisted beyond three months post-infection, and about half recover by six months.
The most common Long COVID symptoms were nasal congestion or runny nose (7.6 per cent), persistent cough (7.4 per cent) and fatigue (3.0 per cent).
It was also found that for children under the age of 18 who were infected with COVID-19, males were about 70 per cent more likely to have Long COVID compared to females.
Dr Li Jiahui, Lead Author of the study, and Head of Infectious Disease Service, Department of Paediatrics, KKH said, “Studies have shown that severe symptoms during acute COVID-19 infection pose a risk factor for Long COVID. Vaccination reduces the risk of severe COVID-19 infection and can potentially confer some protection against Long COVID in children and youths. Keeping up with the COVID-19 and influenza vaccinations remain important in guarding our health and well-being.
"Given the prevalence of Long COVID, it is important for physicians to screen for persisting symptoms in children and youths who had the COVID-19 infection so that we can address these symptoms and assess if there are other causes."
The study was conducted between 14 October 2022 and 15 January 2023, and is one of the first studies in Asia on Long COVID in children and youths, and is the largest, involving 640 participants.
As Singapore is in a new normal, with COVID-19 treated as an endemic infection, it is still important for our vulnerable groups, including pregnant women, children, and adolescents to remain up-to-date with their vaccinations, including against influenza and COVID-19.
<Ends>
For more information, please contact:
Angeline Chen
Manager
Corporate Communications
Tel: 6394 2321
Email: media@kkh.com.sg
Cheryl Leong
Tel: 6394 8558
About KK Women's and Children's Hospital
KK Women’s and Children’s Hospital (KKH) is Singapore’s largest tertiary referral centre for obstetrics, gynaecology, paediatrics and neonatology. The academic medical centre specialises in the management of high-risk conditions in women and children.
Driven by a commitment to deliver compassionate, multidisciplinary care to patients, KKH leverages innovation to advance care. In 2021, the hospital launched the SingHealth Duke-NUS Maternal and Child Health Research Institute (MCHRI). This centre of excellence aims to support the growth of every woman and child to their fullest potential through research and innovation, to transform national heath in Singapore and the region.
Some of the hospital’s recent breakthroughs include uSINE ® , a landmark identification system for the administration of spinal epidural, the discovery of new genetic diseases like Jamuar Syndrome, and a series of guidelines for women and children to improve metabolic and mental health.
The Academic Medical Centre is also a major teaching hospital for Duke-NUS Medical School, Yong Loo Lin School of Medicine and Lee Kong Chian School of Medicine. In addition, KKH runs the largest specialist training programme for Obstetrics and Gynaecology, and Paediatrics in Singapore. The programmes are recognised by the Accreditation Council for Graduate Medical Education International (ACGME-I) and are highly rated for the quality of clinical teaching and translational research.
KKH was founded in 1858 and celebrates its 165 th anniversary this year. For more information, visit www.kkh.com.sg
Follow us on
Facebook | Instagram | LinkedIn | YouTube
[1] Goh O, Pang D, Tan J, Lye D, Chong CY, Ong B, Tan KB, Yung CF (10 November 2023). mRNA SARS-CoV-2 Vaccination Before vs During Pregnancy and Omicron Infection Among Infants. Jama Network Open . 2023;6(11):e2342475. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2811644
[2] Completed first, second and third doses of vaccination
[3] Estimated vaccine effectiveness of 15.4 per cent confers no protection on infants
[4] Li JH, Nadua K, Chong CY, Yung CF (30 October 2023). Long COVID prevalence, risk factors and impact of vaccination in the paediatric population: A survey study in Singapore. Annals Academy of Medicine Singapore. Vol.52 No.10, 522-532. https://annals.edu.sg/long-covid-prevalence-risk-factors-and-impact-of-vaccination-in-the-paediatric-population-a-survey-study-in-singapore/
JAMA
10.1001/jamanetworkopen.2023.42475
mRNA SARS-CoV-2 Vaccination Before vs During Pregnancy and Omicron Infection Among Infants
10-Nov-2023